Somatropin Injection with Various Strengths (5 mg, 10 mg) in 3ml Cartridge Format and 24-Month Shelf Life for Growth Hormone Therapy

Product Description:

Somatropin Injection is a recombinant human growth hormone designed to treat various growth-related disorders. As a vital therapeutic option, Somatropin Injection helps promote growth in children with growth hormone deficiency and supports adults with growth hormone insufficiency. This product belongs to the drug class of recombinant human growth hormone, which is synthetically produced to mimic the natural growth hormone produced by the pituitary gland.

One of the key features of Somatropin Injection is its availability in various strengths to meet individual patient needs. For example, it is commonly supplied in 5 mg and 10 mg per vial dosages, allowing healthcare providers to tailor treatment plans effectively. Additionally, Somatropin Injection is often provided in a convenient 3ml cartridge format, making it easier for administration and dosing accuracy. The 3ml cartridge design ensures that patients can manage their therapy with greater convenience and precision, enhancing compliance and therapeutic outcomes.

Patients using Somatropin Injection should be aware of the potential common side effects. These include injection site reactions such as redness, swelling, or discomfort where the medication is administered. Headache is another frequently reported side effect, which generally subsides over time or with appropriate management. Edema, characterized by swelling due to fluid retention, may also occur and should be monitored by healthcare professionals. Muscle pain or discomfort is another side effect that some patients might experience during treatment. It is important for patients to communicate any adverse reactions to their healthcare provider to ensure safe and effective use of the medication.

The stability and shelf life of Somatropin Injection are also noteworthy. Typically, the product has a shelf life of 24 months when stored under recommended conditions. This relatively long shelf life allows for flexibility in storage and use, ensuring that patients have continuous access to their medication without frequent replacements. Proper storage of the 3ml cartridge is essential to maintain the efficacy and safety of the product throughout its shelf life.

Somatropin Injection's formulation and packaging in the 3ml cartridge system provide a user-friendly approach for patients requiring regular growth hormone therapy. The 3ml cartridge not only facilitates easy handling but also supports accurate dosing, reducing the risk of errors. This is particularly beneficial for pediatric patients who require precise dosing adjustments as they grow. The availability of multiple strengths within this 3ml cartridge format further enhances the versatility of Somatropin Injection across different patient populations.

In summary, Somatropin Injection is a reliable and effective recombinant human growth hormone treatment available in various strengths, including 5 mg and 10 mg per vial, and conveniently packaged in a 3ml cartridge. It offers a practical solution for patients with growth hormone deficiencies, supporting growth and metabolic functions. The product's typical shelf life of 24 months ensures durability and accessibility, while its common side effects such as injection site reactions, headache, edema, and muscle pain are manageable under medical supervision. The innovative 3ml cartridge design enhances patient compliance and dosing accuracy, making Somatropin Injection a preferred choice in growth hormone therapy.

Features:

• Product Name: Somatropin Injection
• Dosage Form: Injection
• Storage Conditions: Refrigerate at 2-8°C, Do Not Freeze
• Strength: Various strengths available (e.g., 5 mg, 10 mg per vial)
• Mechanism of Action: Stimulates growth and cell reproduction by mimicking natural human growth hormone
• Contraindications: Active malignancy, acute critical illness, hypersensitivity to somatropin
• Contains human growth hormone to support growth and development
• Used as a synthetic form of human growth hormone for therapeutic purposes

Technical Parameters:

Applications:

The Delfu Somatropin Injection, model number BZ-18, is a highly effective treatment designed to address various medical conditions associated with human growth hormone deficiencies. Originating from China, this product is formulated to provide reliable and consistent therapy for patients requiring supplemental growth hormone. The Somatropin Injection is primarily indicated for individuals diagnosed with Growth Hormone Deficiency, Turner Syndrome, Chronic Kidney Disease, and Prader-Willi Syndrome, conditions that significantly impact growth and development.

This product is administered either subcutaneously or intramuscularly, offering flexibility in treatment approaches depending on patient needs and medical advice. The injection is often delivered using an injection pen, which enhances ease of use, accuracy in dosing, and patient comfort. The use of an injection pen allows patients and healthcare providers to administer the human growth hormone with greater precision and convenience, making it an essential tool for ongoing treatment regimens.

The Delfu Somatropin Injection has a typical shelf life of 24 months, ensuring long-term usability when stored under recommended conditions. Patients receiving this treatment should be aware of common side effects, which include injection site reactions, headache, edema, and muscle pain. These side effects are generally manageable and should be closely monitored by healthcare professionals to optimize therapy outcomes.

In practical scenarios, the Somatropin Injection is utilized in pediatric and adult patients who require growth hormone supplementation to promote normal growth and metabolic functions. It is especially beneficial in clinical settings where precise dosing and consistent administration are critical. The injection pen facilitates home-based administration, empowering patients or caregivers to manage treatment effectively without frequent hospital visits.

Overall, the Delfu Somatropin Injection BZ-18 represents a vital therapeutic option for those affected by growth hormone-related disorders. Its compatibility with injection pens, proven efficacy, and manageable side effect profile make it a preferred choice in both hospital and outpatient care environments. Whether for chronic kidney disease patients needing growth support or children with Turner Syndrome, this product plays a crucial role in improving quality of life and health outcomes.

Customization:

The Delfu Somatropin Injection, model number BZ-18, is a high-quality recombinant human growth hormone product originating from China. This injection pen is designed for ease of use and precision, containing a 3ml cartridge of active ingredient Somatropin. It works by stimulating growth and cell reproduction by mimicking natural growth hormone, making it an effective treatment option.

Please note that the injection pen should be used with caution and is contraindicated in patients with active malignancy, acute critical illness, or hypersensitivity to Somatropin. Proper storage conditions require refrigerating the injection pen at 2-8°C and avoiding freezing to maintain the medication's efficacy.

Choose the Delfu Somatropin injection pen with a 3ml cartridge for reliable and convenient administration of recombinant human growth hormone therapy.

Support and Services:

For technical support and services related to Somatropin Injection, please refer to the product manual and prescription guidelines provided with the medication. Ensure that the product is stored according to the recommended conditions to maintain its efficacy. If you encounter any issues with the product, such as packaging defects or administration concerns, consult your healthcare provider or pharmacist promptly.

Proper administration of Somatropin Injection is crucial for optimal therapeutic outcomes. Training on injection techniques may be available through your healthcare provider or authorized medical personnel. Report any adverse reactions or unexpected effects to your healthcare professional immediately.

For further information on dosage, storage, handling, and administration procedures, please consult the prescribing information leaflet included with the product packaging or contact your healthcare provider.